Based on Chi3l1 KO mouse phenotypes in the B16F10 melanoma lung metastasis model, we developed a novel tumor treatment agent based on siRNA and cell-penetrating peptide (CPP) complexes. The gene discussed is CHI3L1; the disease is neoplasm.